Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$BLEG .0027 up 29% MASSIVE NEWS OUT!!! Reports Significant Net Income of Over $3.8 Million
https://brandedlegacy.com/branded-legacy-inc-reports-significant-net-income/
The Company's total assets have seen an astronomical increase to $3,787,215.00, the majority in 2024, marking a 1,412% increase compared to the end of Q3. The newly acquired laboratory and packaging equipment significantly bolsters capacities in R&D, production, and packaging.
Apr 16, 2024 | Brands, Company Investment, Manufacturing and Processing, News, Partnerships and Collaborations
Royal Biotek Enhances Everglade Line with New Products
Melbourne, FL – April 16, 2024 – Branded Legacy, Inc. (OTC.PK: BLEG), a leading provider of innovative wellness products, is pleased to announce a net income for the fiscal year 2023 of $3,825,527, a substantial increase driven by the strategic retirement of over 2.4 billion shares. As they forge into 2024, the company has signed multiple on-going white label contracts, poised to further enhance our revenue and profitability for the coming year and beyond.
“2023 was a year of substantial growth and strategic repositioning for Branded Legacy. As we continue to expand and innovate, our focus remains steadfast on leveraging our core strengths in biotechnology to improve human health globally,” said David Oswald, CEO of Branded Legacy.
In a remarkable development, Branded Legacy has welcomed Dr. Mark T. Hamann, the Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy, to guide its forthcoming clinical trials. This follows the Company’s recent strategic acquisition of Sycamore BioPharma, Inc., a distinguished developer of plant-based pharmaceuticals. This acquisition not only secured assets exceeding $2 million but also integrates key personnel vital for advancing their clinical trials.
The company’s recent strategic endeavors include the acquisition of several companies, bringing over $3.7 million worth of advanced scientific equipment and inventory. This expansion has necessitated a move to a larger, state-of-the-art facility in Melbourne, FL, to accommodate their growing operations and align with their commitment to biotechnological advancement and improving human health.
The Company’s total assets have seen an astronomical increase to $3,787,215.00, the majority in 2024, marking a 1,412% increase compared to the end of Q3. The newly acquired laboratory and packaging equipment significantly bolsters capacities in R&D, production, and packaging.
The extensive equipment range acquired includes High-Performance Liquid Chromatography and Gas Chromatography systems, various centrifuges, vacuum ovens, an irradiating flow hood, incubators, and more. This arsenal of advanced tools empowers the Company to conduct precise chemical analyses, foster controlled research environments, and enhance product development efficiency across various stages.
Furthering its expansion strategy, Branded Legacy, Inc. proudly announced its acquisition of MariJ Pharmaceuticals, Inc. This deal significantly broadens their asset base and intellectual property portfolio, integrating a compounding pharmacy license, state-of-the-art supercritical CO2 extraction units, and a fleet of specialized vehicles designed for mobile extraction and refinement.
This strategic acquisition delivers not only a suite of award-winning organic products and formulations but also enhances their operational flexibility and market reach through the addition of specialized vehicles and a mobile repair service. These assets are instrumental in maintaining the efficiency and reach of our operations across multiple states, including Colorado and Tennessee.
The acquisition of All In Extracts Llc. gave Branded Legacy a leg up in production of gummies, producing 20-50,000 units daily. The All In facility near Tampa, FL, has recently staged up production and refinement of mitragynine, as well as production of a proprietary dosing syrup. With several popular products under their Star Hill brand, All In Extracts is a core aspect of Branded Legacy’s growing revenue.
Branded Legacy, Inc. is poised to continue its trajectory of growth, innovation, and market leadership in the biotech and wellness industries.
Investor Relations & Media Contact:
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Time for ask hitting! Skyrocketing soon!
i can't believe why we are not in the pennies and cents already...this should fly exponentially!!!
SUPER MONSTROUS News Out $BLEG - Reports Significant Net Income of Over $3.8 Million
https://brandedlegacy.com/branded-legacy-inc-reports-significant-net-income/
The Company's total assets have seen an astronomical increase to $3,787,215.00, the majority in 2024, marking a 1,412% increase compared to the end of Q3. The newly acquired laboratory and packaging equipment significantly bolsters capacities in R&D, production, and packaging.
Apr 16, 2024 | Brands, Company Investment, Manufacturing and Processing, News, Partnerships and Collaborations
Royal Biotek Enhances Everglade Line with New Products
Melbourne, FL – April 16, 2024 – Branded Legacy, Inc. (OTC.PK: BLEG), a leading provider of innovative wellness products, is pleased to announce a net income for the fiscal year 2023 of $3,825,527, a substantial increase driven by the strategic retirement of over 2.4 billion shares. As they forge into 2024, the company has signed multiple on-going white label contracts, poised to further enhance our revenue and profitability for the coming year and beyond.
“2023 was a year of substantial growth and strategic repositioning for Branded Legacy. As we continue to expand and innovate, our focus remains steadfast on leveraging our core strengths in biotechnology to improve human health globally,” said David Oswald, CEO of Branded Legacy.
In a remarkable development, Branded Legacy has welcomed Dr. Mark T. Hamann, the Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy, to guide its forthcoming clinical trials. This follows the Company’s recent strategic acquisition of Sycamore BioPharma, Inc., a distinguished developer of plant-based pharmaceuticals. This acquisition not only secured assets exceeding $2 million but also integrates key personnel vital for advancing their clinical trials.
The company’s recent strategic endeavors include the acquisition of several companies, bringing over $3.7 million worth of advanced scientific equipment and inventory. This expansion has necessitated a move to a larger, state-of-the-art facility in Melbourne, FL, to accommodate their growing operations and align with their commitment to biotechnological advancement and improving human health.
The Company’s total assets have seen an astronomical increase to $3,787,215.00, the majority in 2024, marking a 1,412% increase compared to the end of Q3. The newly acquired laboratory and packaging equipment significantly bolsters capacities in R&D, production, and packaging.
The extensive equipment range acquired includes High-Performance Liquid Chromatography and Gas Chromatography systems, various centrifuges, vacuum ovens, an irradiating flow hood, incubators, and more. This arsenal of advanced tools empowers the Company to conduct precise chemical analyses, foster controlled research environments, and enhance product development efficiency across various stages.
Furthering its expansion strategy, Branded Legacy, Inc. proudly announced its acquisition of MariJ Pharmaceuticals, Inc. This deal significantly broadens their asset base and intellectual property portfolio, integrating a compounding pharmacy license, state-of-the-art supercritical CO2 extraction units, and a fleet of specialized vehicles designed for mobile extraction and refinement.
This strategic acquisition delivers not only a suite of award-winning organic products and formulations but also enhances their operational flexibility and market reach through the addition of specialized vehicles and a mobile repair service. These assets are instrumental in maintaining the efficiency and reach of our operations across multiple states, including Colorado and Tennessee.
The acquisition of All In Extracts Llc. gave Branded Legacy a leg up in production of gummies, producing 20-50,000 units daily. The All In facility near Tampa, FL, has recently staged up production and refinement of mitragynine, as well as production of a proprietary dosing syrup. With several popular products under their Star Hill brand, All In Extracts is a core aspect of Branded Legacy’s growing revenue.
Branded Legacy, Inc. is poised to continue its trajectory of growth, innovation, and market leadership in the biotech and wellness industries.
Investor Relations & Media Contact:
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Imagine what 2024 CY will bring to the table >> Can't wait for Q1 and more so Q2.... loving it!
SPREAD THE NEWS!!! >> All I can say to the folks here!
To keep it more simple, EXPLOSIVE! >> LOL
MONSTROUS News $BLEG - Reports Significant Net Income of Over $3.8 Million
https://brandedlegacy.com/branded-legacy-inc-reports-significant-net-income/
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million
Apr 15, 2024 | Brands, Company Investment, Manufacturing and Processing, News, Partnerships and Collaborations
Royal Biotek Enhances Everglade Line with New Products
Melbourne, FL – April 16, 2024 – Branded Legacy, Inc. (OTC.PK: BLEG), a leading provider of innovative wellness products, is pleased to announce a net income for the fiscal year 2023 of $3,825,527, a substantial increase driven by the strategic retirement of over 2.4 billion shares. As they forge into 2024, the company has signed multiple on-going white label contracts, poised to further enhance our revenue and profitability for the coming year and beyond.
“2023 was a year of substantial growth and strategic repositioning for Branded Legacy. As we continue to expand and innovate, our focus remains steadfast on leveraging our core strengths in biotechnology to improve human health globally,” said David Oswald, CEO of Branded Legacy.
In a remarkable development, Branded Legacy has welcomed Dr. Mark T. Hamann, the Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy, to guide its forthcoming clinical trials. This follows the Company’s recent strategic acquisition of Sycamore BioPharma, Inc., a distinguished developer of plant-based pharmaceuticals. This acquisition not only secured assets exceeding $2 million but also integrates key personnel vital for advancing their clinical trials.
The company’s recent strategic endeavors include the acquisition of several companies, bringing over $3.7 million worth of advanced scientific equipment and inventory. This expansion has necessitated a move to a larger, state-of-the-art facility in Melbourne, FL, to accommodate their growing operations and align with their commitment to biotechnological advancement and improving human health.
The Company’s total assets have seen an astronomical increase to $3,787,215.00, the majority in 2024, marking a 1,412% increase compared to the end of Q3. The newly acquired laboratory and packaging equipment significantly bolsters capacities in R&D, production, and packaging.
The extensive equipment range acquired includes High-Performance Liquid Chromatography and Gas Chromatography systems, various centrifuges, vacuum ovens, an irradiating flow hood, incubators, and more. This arsenal of advanced tools empowers the Company to conduct precise chemical analyses, foster controlled research environments, and enhance product development efficiency across various stages.
Furthering its expansion strategy, Branded Legacy, Inc. proudly announced its acquisition of MariJ Pharmaceuticals, Inc. This deal significantly broadens their asset base and intellectual property portfolio, integrating a compounding pharmacy license, state-of-the-art supercritical CO2 extraction units, and a fleet of specialized vehicles designed for mobile extraction and refinement.
This strategic acquisition delivers not only a suite of award-winning organic products and formulations but also enhances their operational flexibility and market reach through the addition of specialized vehicles and a mobile repair service. These assets are instrumental in maintaining the efficiency and reach of our operations across multiple states, including Colorado and Tennessee.
The acquisition of All In Extracts Llc. gave Branded Legacy a leg up in production of gummies, producing 20-50,000 units daily. The All In facility near Tampa, FL, has recently staged up production and refinement of mitragynine, as well as production of a proprietary dosing syrup. With several popular products under their Star Hill brand, All In Extracts is a core aspect of Branded Legacy’s growing revenue.
Branded Legacy, Inc. is poised to continue its trajectory of growth, innovation, and market leadership in the biotech and wellness industries.
Investor Relations & Media Contact:
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Bro! this time the FUD characters are right...get ready for Pink Limited soon if they don't file by tonight. I am already out before these last few drops. Like said before sold 50k at .45+ with decent profit and sold another 50k at under .20 with some loss. My breakeven was .35 for 100k shares in total. All in all came out breakeven with almost $35k of my initial investment. I would rather re-join the party once I see the company starts delivering what they promised months ago. I already made decent profit once before when I got in at .19 and sold at .65 and then re-entered with 100k shares in low .40's and .30's (averaging at .35). And now 100% out!!!
My long investments is in BL__EG and SP__QS which are looking much much better and are in its prime time for HUGE EXPLOSIVE days coming very very soon. You can surely find me there... I am not a basher but a true guider -- listen to my posting from yesterday on ACC/DIST line...call me whatever you want. You will find the truth very very soon! You saw 175k dumped yesterday...watch many more to come if this company doesn't open up to the public soon on all the pending stuff.
All the best to everyone!
https://stocktwits.com/TheBigUglyBear/message/569685959
Btw. this is an OTC stock, anything is possible here...I could be wrong too but what I am seeing is what I am trying to share with my friends here. Good luck!
Your favorite Clown LOL
Joined Ihub/OTC since 1999
(Y2K rollover period)
We are looking for a "MOMSTROUS EXPLOSION" as soon as the "BIG MERGER" News is out stating that the FINAL Acquisition has been COMPLETED.
Everything here is full of excitement. Regardless it is Q1, Q2 or Contracts..this will have its MONSTROUS DAYs soon! 😁
Looks like going under .01 soon...that is where I can think of adding more. Lol
Oh wow! 120k sell today so far..down to .01505 now. Let's hope we see 10k filing by COB with some handsome revenue reporting, otherwise we will all be screwed 😉 😀
Load as much you can...won't see this low levels in the future. Not even close to it.
It is coming for sure...in the very very near future. I am holding strong and long. Would like to Silver ranges soon.
Glad i was out pre R/S. This is not looking good at all. Already lost 50% post R/S..Ugly!!!
You will learn very soon! It has already halved from where it was 1 month ago (.34 high) and lost almost 2/3rd of its value from 1.5 months ago (.575 high) and lost 80% of its value from 6 months ago (.83 high)...keep dreaming folks! Now only left with 2 employees: Interim CEO and New CFO to run this whole $200m business they claim >> what a joke it has become....seriously! LOL
One thing to warn you all based on this chart analysis that I closely and always watch is the Accu/Distr line. It is way too high (way up in the overbought range), which is not a good sign. In 99% cases, this line is supposed to be in the bottom area so the stock has room to run. Check any stock that has recently moved higher has this indicator at the oversold area. Even check where BLFR Accu/Dist line was when it first jumped multiple 1000% 7-8 months ago.
I have seen big dump taking place or an R/S happening when stock has reached such an overbought level. Not to scare but one to do their proper homework.
https://stockcharts.com/sc3/ui/?s=BLFR
Select Accu/Distribution line under Indicators at the bottom selection.
Awesome buddy!
$BLEG .0022 The BEST of the BEST $$$
Would love to see that 😍
Just looking forward for Q1 release and Mega Extraction contract...hopefully all this week. Huge Kaboom should come sooner than later $$$
Besides, smaller contracts will keep coming throughout Q2 and beyond. Looking lovely so far 😁
Yes, the D series are used for all acquisitions past and future. That is why he stated that he may have to increase A/S for D series in future if there to be a lucrative opportunity to acquire another revenue generating profitable company.
Thanks for confirming, PoP!
Dave, the CEO will be the best person to explain you the distribution of all these A-E series Preferred Shares and who got what and when can one be able to sell and how many have been sold so far (converted into common shares).
Please tweet him with your questions or call him directly at 877 814 4188 opt 4 (Royal Biotek) OR try this number 844 714 2224. Since I jusr spoke with him last week with bunch of my inquiries, I don't feel like calling him again. I believe everyone should play their part and share their DD here as a true and sincere BLEG investor. This is a team project where we all benefit if done correctly. All the best 👍
AMEN! The other ticker symbol I also see going much much higher is BLEG. The SS is much lower than this one, i.e. A/S 900m and O/S 676m. Recently acquired 5 companies in past 6 months. Signed 500m worth of contracts in just last week and a HUGE one is pending to be released anytime now. Very very transparent CEO. Alais "ace65" is on it as well. There are much bigger ihub investors on it as well.
Thanks Toddles for backing it up with reasonings. I 100% see huge reversal from these levels. My charts are showing SPQS sitting at VERY bottom. I can only see it rising up from here and beyond. I believe once the FINAL merger PR is out for complete take over, it will shoot up 300-500% on a very high volume. Hopefully next week to be the week.
Trying to stay strong and positive and the rest I would leave to God to help us all to win this race against the bashers or any ill-intented people (even that means the company itself if they have any wrong intentions here). Good luck to everyone!
Yes indeed...now 10Q and Major Extraction contract next...hoping this coming week.
Now that 10k is out...next week will be 10Q for Q1 >>> looking good!
10k filing is out!
https://www.otcmarkets.com/stock/BLEG/disclosure
Oh no! Please don't act like a crying baby...I would like to hear from real investors. Why bring up 2 months old float numbers when the company just stated no dilution 2 days ago. Also, mergers doesn't happen free of cost..the acquiring company has to sell shares to raise money if the deal is based on outstanding or preferred shares as well as some cash money upfront. A daily volume of 20-50m doesn't scary me or my investment. Take care! 😁 And best of luck for next week.
This WILL fly...and it will be fairly soon!
JMO!
Happy Weekend to you as well. Wow! That is surely a huge volume...what is up?
I wonder why would retailers be selling at this pps?? 🤔 LOL
I think it is more like MMs game...exchanging shares between each other and/or the same time creating fear so they can get more of our shares as well.
So so ready to fly...possibly tomorrow, if not, next week for sure...I am excited!
Everything is coming together on this mega merger deal.
BLEG will surprise many of us...be ready to take your positions before it is too late. $$$
$BLEG. 0026 Super thin! Awaiting financials should take us to next level up....004+
$BLEG .0026 ready for next leg up. Super thin!
And btw. Let Nick know to keep hitting the ask and stop all the bs he has been talking about for last 8 months. 😆
Good job buddy! Keep up the good work. Lol
This is absolutely pathetic....is this another Chinese Scams???
Another round of selling...I hope it ends here